|
[Related PubMed/MEDLINE]
Total Number of Papers: 746
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
Cerebral Organoids Maintain the Expression of Neural Stem Cell-Associated Glycoepitopes and Extracellular Matrix. |
CNS, ECM, LeX, mAb |
| 2 |
2022 |
Diagnostic Value of Aortic Dissection Risk Score, Coagulation Function, and Laboratory Indexes in Acute Aortic Dissection. |
AAD, ACS, AD, APTT, DD, FDP, FIB, PT, ROC |
| 3 |
2022 |
Effect of Shengmai Yin on the DNA methylation status of nasopharyngeal carcinoma cell and its radioresistant strains. |
CNE-2R, NPC, SMY |
| 4 |
2022 |
Engineering a Mechanoactive Fibrous Substrate with Enhanced Efficiency in Regulating Stem Cell Tenodifferentiation. |
ADSCs, Col I, PLCL, SCX, SME, TNMD |
| 5 |
2022 |
Ephrin B Activate Src Family Kinases in Fibroblasts Inducing Stromal Remodeling in Prostate Cancer. |
CAF, Eph, PCa, SFK |
| 6 |
2022 |
Identification of Significant Genes and Pathways Associated with Tenascin-C in Cancer Progression by Bioinformatics Analysis. |
DEGs, GO, PPI |
| 7 |
2022 |
Influence of the microenvironment dynamics on extracellular matrix evolution under hypoxic ischemic conditions in the myocardium. |
ECM |
| 8 |
2022 |
Mechanical Compression of Human Airway Epithelial Cells Induces Release of Extracellular Vesicles Containing Tenascin C. |
EVs, HBE |
| 9 |
2022 |
Mesangial cell-derived tenascin-C contributes to mesangial cell proliferation and matrix protein production in IgA nephropathy. |
IgAN, MEST score |
| 10 |
2022 |
Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, "MAREMO". |
FN, TME |
| 11 |
2022 |
Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs. |
ECs, NO, TLR4, TNF, VEGF |
| 12 |
2022 |
Serum Tenascin-C and Alarin Levels Are Associated with Cardiovascular Diseases in Type 2 Diabetes Mellitus. |
AUC, CVD, ELISA, ROC, T2DM |
| 13 |
2022 |
Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases Identified That TNC Is a Novel Biomarker for Keloid. |
--- |
| 14 |
2022 |
Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1. |
DpC, NDRG1, PC, PSCs, TGF |
| 15 |
2022 |
Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas. |
CGGA, LGGs |
| 16 |
2022 |
Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation. |
BCa, ECM, LSCM |
| 17 |
2022 |
Tenascin-C restricts reactive astrogliosis in the ischemic brain. |
ICAM-1 |
| 18 |
2022 |
Tenascins Interfere With Remyelination in an Ex Vivo Cerebellar Explant Model of Demyelination. |
ECM, OPCs, TN-R |
| 19 |
2022 |
The expression and role of tenascin C in abdominal aortic aneurysm formation and progression. |
AAA, VSMC, WT |
| 20 |
2022 |
The extracellular matrix molecule tenascin-C modulates cell cycle progression and motility of adult neural stem/progenitor cells from the subependymal zone. |
aNSPCs, CNS, ECM, EGF, LN-1, PDL, SEZ, SGZ |
| 21 |
2021 |
Chondrocyte protein co-synthesis network analysis links ECM mechanosensing to metabolic adaptation in osteoarthritis. |
COL11A1, COMP, ECM, OA |
| 22 |
2021 |
Comparison of preoperative serum neopterin, periostin, indoleamine 2,3-dioxygenase, YKL-40, and tenascin-C levels with current tumor markers for early-stage endometrial cancer. |
CEA, IDO |
| 23 |
2021 |
Converging purinergic and immune signaling pathways drive IL-6 secretion by Fragile X cortical astrocytes via STAT3. |
FXS, IL-6, KO |
| 24 |
2021 |
Deregulation of extracellular matrix modeling with molecular prognostic markers revealed by transcriptome sequencing and validations in Oral Tongue squamous cell carcinoma. |
DSG2, E-cad, FOXM1, MMP-9, MYO1B, OTSCC, PDPN, PLAU |
| 25 |
2021 |
Detection of osteoarthritis in dogs by metabolic, pro-inflammatory and degenerative synovial fluid biomarkers and traditional radiographic screening: A pilot study. |
IL-1beta, MMP-2, OA, SF, TNF-alpha |
| 26 |
2021 |
Different Functions of Recombinantly Expressed Domains of Tenascin-C in Glial Scar Formation. |
SCI |
| 27 |
2021 |
Direct in vivo reprogramming with non-viral sequential targeting nanoparticles promotes cardiac regeneration. |
CFs, iCMs, MSNs |
| 28 |
2021 |
Elevated glucose alters global gene expression and tenascin-C alternative splicing in mesangial cells. |
ECM, FN |
| 29 |
2021 |
Elevated Serum Tenascin-C Predicts Mortality in Critically Ill Patients With Multiple Organ Dysfunction. |
APACHE II, SAPS II, SOFA |
| 30 |
2021 |
Endometrial gene expression profiling of recurrent implantation failure after in vitro fertilization. |
ddPCR, FOXP3, IVF, KEGG, MME, PANOGA, RIF, WWC1 |
| 31 |
2021 |
Evaluation of the Effect of Hyaluronic Acid-Based Biomaterial Enriched With Tenascin-C on the Behavior of the Neural Stem Cells. |
HA, NSCs |
| 32 |
2021 |
Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-beta in Triggering Inflammatory Signals in Cells of Distant Organ. |
FGB, IL-6, NF-kappaB, TNF-alpha |
| 33 |
2021 |
Expression Patterns of Microenvironmental Factors and Tenascin-C at the Invasive Front of Stage II and III Colorectal Cancer: Novel Tumor Prognostic Markers. |
CAF, CRC |
| 34 |
2021 |
Extracellular matrix remodeling precedes atrial fibrillation: Results of the PREDICT-AF trial. |
AF, BGN, EDN1, PREDICT-AF, THBS2 |
| 35 |
2021 |
Extracellular Vesicles: An Emerging Mechanism Governing the Secretion and Biological Roles of Tenascin-C. |
ECM, EVs, FN |
| 36 |
2021 |
Fibroblast Growth Factor 2 Augments Transforming Growth Factor Beta 1 Induced Epithelial-mesenchymal Transition in Lung Cell Culture Model. |
ACTA2, EMT, FGF-2, FN, TGF-beta1 |
| 37 |
2021 |
Generation of Transgenic Mice that Conditionally Overexpress Tenascin-C. |
--- |
| 38 |
2021 |
Human Cerebral Cortex Proteome of Fragile X-Associated Tremor/Ataxia Syndrome. |
CD38, CNS, FMR1, FXTAS, PSAT1 |
| 39 |
2021 |
Immunohistochemical Comparative Study of Aggressive and Non-aggressive Central Giant Cell Lesions of the Jaws Based on the Tenascin-C Expression Profile. |
CGCLs, MGC, MVC |
| 40 |
2021 |
Immunomodulatory Role of Tenascin-C in Myocarditis and Inflammatory Cardiomyopathy. |
--- |
| 41 |
2021 |
Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph Nodes. |
OSCC, TIL, TME |
| 42 |
2021 |
Increased Tenascin C, Osteopontin and HSP90 Levels in Plasmatic Small Extracellular Vesicles of Pediatric ALK-Positive Anaplastic Large Cell Lymphoma: New Prognostic Biomarkers? |
ALCL, ALK, HDs, HSP90AA1, KEGG, NPM, PI3K, sEVs |
| 43 |
2021 |
Influence of microcurrent on the modulation of remodelling genes in a wound healing assay. |
CTGF, FMOD, IGF1, MC, Scx, TGFB |
| 44 |
2021 |
Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression. |
--- |
| 45 |
2021 |
Knock-Out of Tenascin-C Ameliorates Ischemia-Induced Rod-Photoreceptor Degeneration and Retinal Dysfunction. |
ECM, ERG, I/R, KO, VGLUT1, WT |
| 46 |
2021 |
Latent TGF-beta Activation Is a Hallmark of the Tenascin Family. |
EMT, FBG, LAP, TGF-beta, TN-R, TN-W, TNX |
| 47 |
2021 |
Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker. |
ECM, GEO, TMA, TN, TNX |
| 48 |
2021 |
Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-kappaB/miR-155-5p inflammatory loop. |
CTGF, DKD, ELISA, FN, GFR, RMCs, T2DM, TLR4, UACR |
| 49 |
2021 |
MicroRNA‑218 inhibits the malignant phenotypes of glioma by modulating the TNC/AKT/AP‑1/TGFβ1 feedback signaling loop. |
TGF-beta1 |
| 50 |
2021 |
Noggin Overexpression Impairs the Development of Muscles, Tendons, and Aponeurosis in Soft Palates by Disrupting BMP-Smad and Shh-Gli1 Signaling. |
BMP, HPP, LVP, PLP, TVP |
| 51 |
2021 |
Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies. |
ECM, hTNC |
| 52 |
2021 |
Potential major depressive disorder biomarkers in pediatric population - a pilot study. |
MDD, PRDX1 |
| 53 |
2021 |
Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma. |
COX-2, LVSI, Rad-score |
| 54 |
2021 |
Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition. |
BMP4, CM, ECs, PCa |
| 55 |
2021 |
Proteomic Analysis Reveals Key Proteins in Extracellular Vesicles Cargo Associated with Idiopathic Pulmonary Fibrosis In Vitro. |
ECM, EVs, FBN1, IGFBP7, IPF, LOXL1 |
| 56 |
2021 |
Relationships Between Circulating Tenascin-C Levels and Gonadal Hormones in Male Patients with Depressive Disorder: A Retrospective, Cross-Sectional Study. |
TSH |
| 57 |
2021 |
Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study. |
CALs, IVIG, KD |
| 58 |
2021 |
Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis. |
CCP, cit-TNC, RA |
| 59 |
2021 |
Systemic Proteomic Analysis Reveals Distinct Exosomal Protein Profiles in Rheumatoid Arthritis. |
AGT, COMP, LBP, RA, TTR |
| 60 |
2021 |
Tenascin C Has a Modest Protective Effect on Acute Lung Pathology during Methicillin-Resistant Staphylococcus aureus-Induced Pneumonia in Mice. |
MRSA |
| 61 |
2021 |
Tenascin C Promotes Glioma Cell Malignant Behavior and Inhibits Chemosensitivity to Paclitaxel via Activation of the PI3K/AKT Signaling Pathway. |
--- |
| 62 |
2021 |
Tenascin-C Deficiency Is Associated With Reduced Bacterial Outgrowth During Klebsiella pneumoniae-Evoked Pneumosepsis in Mice. |
--- |
| 63 |
2021 |
Tenascin-C in Heart Diseases-The Role of Inflammation. |
ECM |
| 64 |
2021 |
Tenascin-C induction exacerbates post-stroke brain damage. |
--- |
| 65 |
2021 |
Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT. |
VM |
| 66 |
2021 |
Tenascin-C Participates Pulmonary Injury Induced by Paraquat Through Regulating TLR4 and TGF-β Signaling Pathways. |
PQ |
| 67 |
2021 |
Tenascin-C promotes epithelial-to-mesenchymal transition and the mTOR signaling pathway in nasopharyngeal carcinoma. |
EMT, NPC |
| 68 |
2021 |
Tenascin-C regulates migration of SOX10 tendon stem cells via integrin-α9 for promoting patellar tendon remodeling. |
DEGs, integrin-alpha9 |
| 69 |
2021 |
Tenascin-C-mediated suppression of extracellular matrix adhesion force promotes entheseal new bone formation through activation of Hippo signalling in ankylosing spondylitis. |
AS, ECM, FSP1, scRNA-seq |
| 70 |
2021 |
Tenascin-C: Friend or Foe in Lung Aging? |
ECM, HTV, WT |
| 71 |
2021 |
The expression of tenascin-C in neural stem/progenitor cells is stimulated by the growth factors EGF and FGF-2, but not by TGFβ1. |
ECM, EGF, FGF, NSPCs, TGF |
| 72 |
2021 |
The Extracellular Matrix Glycoprotein Tenascin C and Adult Neurogenesis. |
CNS, ECM |
| 73 |
2021 |
The long non-coding RNA ET-20 mediates EMT by impairing desmosomes in breast cancer cells. |
EMT, lncRNAs |
| 74 |
2021 |
The neuroprotective function of 2-carba-cyclic phosphatidic acid: Implications for tenascin-C via astrocytes in traumatic brain injury. |
2ccPA, TBI |
| 75 |
2021 |
The Role of Tenascin C in Cardiac Reverse Remodeling Following Banding-Debanding of the Ascending Aorta. |
alpha-SMA, COL1, HCFs, LV, TN-C KO, WT |
| 76 |
2021 |
The role of Tenascin-C in HIV associated pre-eclampsia. |
PE |
| 77 |
2021 |
The Role of Tenascin-C in Tissue Injury and Repair After Stroke. |
SAH |
| 78 |
2021 |
The usefulness of biomarkers in diagnosis of asbestos-induced malignant pleural mesothelioma. |
IDO, MPM |
| 79 |
2020 |
Anoikis resistance conferred by tenascin-C-derived peptide TNIIIA2 and its disruption by integrin inactivation. |
GBM |
| 80 |
2020 |
Assessment of serum tenascin-C and growth differentiation factor-15 among type 2 diabetes mellitus patients with and without acute coronary syndrome. |
ACS, CK-MB, CK-T, GDF15, T2DM |
| 81 |
2020 |
Characterization of Bone Marrow and Wharton's Jelly Mesenchymal Stromal Cells Response on Multilayer Braided Silk and Silk/PLCL Scaffolds for Ligament Tissue Engineering. |
BM-MSCs, Col I, Col III, PLCL, WJ-MSCs |
| 82 |
2020 |
Delta9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice. |
Delta9-THCA, DIO, HFD, NAFLD |
| 83 |
2020 |
Dose-Response Tendon-Specific Markers Induction by Growth Differentiation Factor-5 in Human Bone Marrow and Umbilical Cord Mesenchymal Stem Cells. |
COL1A1, DCN, hGDF-5, SCX-A, TNMD |
| 84 |
2020 |
Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment. |
ECM, EMT |
| 85 |
2020 |
ECM deposition is driven by caveolin-1-dependent regulation of exosomal biogenesis and cargo sorting. |
Cav-1, ECM, MVBs |
| 86 |
2020 |
Effects of Tenascin C on the Integrity of Extracellular Matrix and Skin Aging. |
ECM, TGF-beta1, TNC-L |
| 87 |
2020 |
Elevated Tenascin-C Serum Levels in Patients With Axial Spondyloarthritis. |
axSpA, BASDAI, CRP, HS |
| 88 |
2020 |
Enhanced Growth of Lapine Anterior Cruciate Ligament-Derived Fibroblasts on Scaffolds Embroidered from Poly(l-lactide-co-epsilon-caprolactone) and Polylactic Acid Threads Functionalized by Fluorination and Hexamethylene Diisocyanate Cross-Linked Collagen Foams. |
ACLs, DCN, EDC, HMDI, q-PCR, sGAG, TNMD |
| 89 |
2020 |
Enhanced tendon restoration effects of anti-inflammatory, lactoferrin-immobilized, heparin-polymeric nanoparticles in an Achilles tendinitis rat model. |
COX-2, DCN, IL-1beta, MMP-3, TNF-alpha |
| 90 |
2020 |
Eosinophil accumulation in postnatal lung is specific to the primary septation phase of development. |
ECM |
| 91 |
2020 |
Factors Associated with Ineffectiveness of Sildenafil Treatment in Patients with End-Stage Heart Failure and Elevated Pulmonary Vascular Resistance. |
HF, HT, PVR, RVEDD |
| 92 |
2020 |
Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties. |
CP, Na, PDAC |
| 93 |
2020 |
Foxo3a aggravates inflammation and induces apoptosis in IL-1-treated rabbit chondrocytes via positively regulating tenascin-c. |
OA |
| 94 |
2020 |
Generation and characterization of dromedary Tenascin-C and Tenascin-W specific antibodies. |
TNW |
| 95 |
2020 |
IL-33/ST2 axis promotes glioblastoma cell invasion by accumulating tenascin-C. |
IL-33, NF-kappaB |
| 96 |
2020 |
Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide. |
ECM, MMPs, pFN, TME |
| 97 |
2020 |
Loss of the Extracellular Matrix Molecule Tenascin-C Leads to Absence of Reactive Gliosis and Promotes Anti-inflammatory Cytokine Expression in an Autoimmune Glaucoma Mouse Model. |
CO, EAG, ECM, IOP, ONA, RGCs |
| 98 |
2020 |
Myofiber necroptosis promotes muscle stem cell proliferation via releasing Tenascin-C during regeneration. |
EGFR, MLKL, MuSC, RIPK1 |
| 99 |
2020 |
Patients with enthesitis related arthritis show similar monocyte function pattern as seen in adult axial spondyloarthropathy. |
ERA, HC, LPS, MRP, PG, SFMC, TLR, WB |
| 100 |
2020 |
Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy. |
HRECs, IL-13, IPR, OIR, PDR, PN |
|
A Search Service for Abbreviation / Long Form
